Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia
GQGenotyping quality control and imputation of the 14 independent cohorts were performed by the PGC Statistical Analysis Group. Each dataset was processed separately. Experimental details are described in the Additional file
Indexed incrossrefdoajpubmed
Abstract
BACKGROUND: Over the past decade genome-wide association studies (GWAS) have been applied to aid in the understanding of the biology of traits. The success of this approach is governed by the underlying effect sizes carried by the true risk variants and the corresponding statistical power to observe such effects given the study design and sample size under investigation. Previous ASD GWAS have identified genome-wide significant (GWS) risk loci; however, these studies were of only of low statistical power to identify GWS loci at the lower effect sizes (odds ratio (OR)
Citation impact
643
total citations
- FWCI
- 64.70
- Percentile
- 100%
- References
- 87
Citations per year
Authors
1- GQGenotyping quality control and imputation of the 14 independent cohorts were performed by the PGC Statistical Analysis Group. Each dataset was processed separately. Experimental details are described in the Additional fileCorresponding
Topics & keywords
Topics
Keywords
- Schizophrenia spectrum
- Genome-wide association study
- Autism spectrum disorder
- Autism
- Schizophrenia (object-oriented programming)
- Neuropsychology
- Psychology
- Psychiatry
No related works found for this paper.
Funding
- ASAutism Speaks
- BBattelle
- MGMassachusetts General Hospital
- YUYale UniversityAward: CT 06520
- UOUniversity of Southern California
- BUBrown University
- VUVanderbilt University
- UOUniversity of Miami
- UOUniversity of Pennsylvania
- UOUniversity of Minnesota
- NCNationwide Children's Hospital
- AUAarhus Universitet
- AUAarhus Universitetshospital
- UOUniversity of WashingtonAward: WA 98195
- JHJohns Hopkins University
- UOUniversity of Pittsburgh
- CMCarnegie Mellon University
- MUMcGill University
- RURush University
- DKDeutsches KrebsforschungszentrumAwards: 69120, D-69120
- GCGenome Canada
- MUMcMaster University
- WTWellcome Trust
- HRHealth Research Board
- BIBroad Institute
- URUkrainian Research Institute, Harvard University
- UOUniversity of Alberta
- UOUniversity of Oxford
- NUNewcastle University
- CUCardiff University
- UCUniversity College Dublin
- TCTrinity College Dublin
- INInstitut National de la Santé et de la Recherche Médicale
- LLundbeckfonden
- UOUniversity of Toronto
- KIKarolinska Institutet
- UDUniversité de Toulouse
- RHRegion Hovedstaden
- UDUniversidade de Coimbra
- UDUniversità di Bologna
- HFHospital for Sick Children
- HLH. Lundbeck A/S
- UOUniversity of Illinois at Urbana-Champaign
- UOUniversity of California, Los Angeles
- WCWeill Cornell Medical College
- UOUniversity of North Carolina at Chapel Hill
- JHJohns Hopkins Bloomberg School of Public Health
- SOSchool of Medicine, Indiana University
- RIResearch Institute, Nationwide Children's Hospital
- SCStanley Center for Psychiatric Research, Broad Institute
- FBFriedman Brain Institute, Icahn School of Medicine at Mount Sinai
- DODepartment of Psychiatry, University of Toronto
- RJRoy J. and Lucille A. Carver College of Medicine, University of Iowa
- MCMindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai
- CICanadian Institutes of Health Research
- MRMedical Research CouncilAwards: MR/P005748/1, MR/L010305/1
- SSStatens Serum Institut
- NINational Institute of Mental HealthAward: MH100027
- DGDavid Geffen School of Medicine, University of California, Los Angeles
- JAJane and Terry Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles